Møgelvang B
Skodsborg Sanatorium.
Nord Med. 1992;107(2):53-6.
The very extensive research into atherogenesis carried out in recent years has yielded new knowledge of the importance of oxidation by free radicals of low-density lipoproteins and lipids, for instance in endothelial cell membrane. This has provided greater insight into the potential benefit of preventive measures using anti-oxidants to inhibit atherogenesis, and the results of clinical trials carried out so far would seem to confirm this. Prospective, controlled epidemiological trials are still lacking, but this will probably be remedied within the next 2-3 decades. The most clinically interesting antioxidants are vitamins C and E, beta-carotene, the ubiquinones, and the trace element selenium, substances that are naturally integrated components of the complex biochemistry of the human organism. The review is intended to clarify the scientific rationale for an increased intake of such anti-oxidants with a view to reducing the incidence of ischaemic vascular disorders.
近年来,针对动脉粥样硬化形成开展的广泛研究,已经产生了关于低密度脂蛋白和脂质的自由基氧化作用重要性的新知识,例如在内皮细胞膜中的作用。这为使用抗氧化剂抑制动脉粥样硬化形成的预防措施的潜在益处提供了更深入的见解,并且迄今为止进行的临床试验结果似乎证实了这一点。前瞻性、对照流行病学试验仍然缺乏,但这可能会在未来20至30年内得到弥补。临床上最受关注的抗氧化剂是维生素C和E、β-胡萝卜素、泛醌以及微量元素硒,这些物质是人体复杂生物化学过程中自然整合的组成部分。这篇综述旨在阐明增加此类抗氧化剂摄入量以降低缺血性血管疾病发病率的科学依据。